These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11880373)

  • 1. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.
    Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
    J Biol Chem; 2002 May; 277(19):16847-52. PubMed ID: 11880373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of bradykinin B1 receptor by ACE inhibitors.
    Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
    Int Immunopharmacol; 2002 Dec; 2(13-14):1787-93. PubMed ID: 12489793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
    Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
    Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.
    Marcic BM; Erdös EG
    J Pharmacol Exp Ther; 2000 Aug; 294(2):605-12. PubMed ID: 10900238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells.
    Stanisavljevic S; Ignjatovic T; Deddish PA; Brovkovych V; Zhang K; Erdös EG; Skidgel RA
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1153-8. PubMed ID: 16282523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of bradykinin and resensitization of its B2 receptor.
    Marcic B; Deddish PA; Jackman HL; Erdös EG
    Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
    Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
    Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
    Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
    J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor.
    Deddish PA; Marcic BM; Tan F; Jackman HL; Chen Z; Erdös EG
    Hypertension; 2002 Feb; 39(2 Pt 2):619-23. PubMed ID: 11882619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
    Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
    Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K; Andersson RG
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACE inhibitors--activators of kinin receptors].
    Kugaevskaia EV; Eliseeva IuE
    Biomed Khim; 2011; 57(3):282-99. PubMed ID: 21863742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
    Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
    Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor?
    Fortin JP; Gobeil F; Adam A; Regoli D; Marceau F
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H277-82. PubMed ID: 12649080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors.
    Hecker M; Pörsti I; Busse R
    Braz J Med Biol Res; 1994 Aug; 27(8):1917-21. PubMed ID: 7749381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?
    Tom B; Dendorfer A; Danser AH
    Int J Biochem Cell Biol; 2003 Jun; 35(6):792-801. PubMed ID: 12676166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.
    Scharfstein J; Schmitz V; Morandi V; Capella MM; Lima AP; Morrot A; Juliano L; Müller-Esterl W
    J Exp Med; 2000 Nov; 192(9):1289-300. PubMed ID: 11067878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells.
    Busse R; Lamontagne D
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):126-9. PubMed ID: 1663586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
    Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
    Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
    Mombouli JV; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.